Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 29, 2021, Falcon Capital Acquisition Corp., a Delaware corporation ("FCAC" or the "Company"), held a special meeting of stockholders (the "Special Meeting"). At the Special Meeting, a total of 32,952,806 (76.41%) of FCAC's issued and outstanding shares of common stock held of record as of May 10, 2021, the record date for the Special Meeting, were present either in person or by proxy, which constituted a quorum. FCAC's stockholders voted on the following proposals at the Special Meeting, each of which was approved. The final vote tabulation for each proposal is set forth below.

1. The Business Combination Proposal - To approve the agreement and plan of


    merger, dated as of February 12, 2021 (as may be amended and/or restated from
    time to time, the "Merger Agreement"), by and among FCAC; FCAC Merger Sub
    Inc., a Delaware corporation and a wholly-owned subsidiary of FCAC ("Merger
    Sub"); Sharecare, Inc., a Delaware corporation ("Sharecare"); and Colin
    Daniel, solely in his capacity as representative of the stockholders of
    Sharecare, and the transactions contemplated thereby, pursuant to which Merger
    Sub will merge with and into Sharecare with Sharecare surviving the merger as
    a wholly owned subsidiary of FCAC (the transactions contemplated by the Merger
    Agreement, the "Business Combination"). In addition, in connection with the
    consummation of the Business Combination, FCAC will be renamed "Sharecare,
    Inc." and is referred to as "New Sharecare" as of the time following such
    change of name:




Votes For    Votes Against   Abstentions
32,080,366      866,108         6,332



2. The Charter Proposal - To approve, assuming the Business Combination Proposal


    is approved and adopted, the proposed fourth amended and restated certificate
    of incorporation of FCAC, which includes a certificate of designations for the
    Series A Preferred Stock ("Series A Preferred Stock") (the "Proposed
    Charter"), which will replace FCAC's third amended and restated certificate of
    incorporation, dated September 21, 2020 (the "Current Charter") and will be in
    effect upon the Closing of the Business Combination:




Votes For    Votes Against   Abstentions
32,078,346      866,668         7,792




                                       1




3. Advisory Charter Proposal - To approve, on a non-binding advisory basis, the


    following material difference between the Proposed Charter and the Current
    Charter, which is being presented in accordance with the requirements of the
    SEC as a separate sub-proposal:



Under the Proposed Charter, New Sharecare will be authorized to issue 615,000,000 shares of capital stock, consisting of (a) 600,000,000 shares of common stock, par value $0.0001 per share and (b) 15,000,000 shares of preferred stock, par value $0.0001 per share, including 5,000,000 shares of New Sharecare Series A Preferred Stock, as opposed to the Current Charter which authorizes FCAC to issue 401,000,000 shares of capital stock, consisting of (y) 400,000,000 shares of common stock, including 380,000,000 shares of Class A common stock, par value $0.0001 per share, and 20,000,000 shares of Class B common stock, par value $0.0001 per share, and (z) 1,000,000 shares of preferred stock, par value $0.0001 per share:





Votes For    Votes Against   Abstentions
31,425,105      894,838        632,863



4. The Stock Issuance Proposal - To approve, assuming the Business Combination


    Proposal and the Charter Proposal are approved and adopted, for the purposes
    of complying with the applicable listing rules of Nasdaq, the issuance of (i)
    shares of FCAC Class A common stock and the New Sharecare Series A Preferred
    Stock pursuant to the terms of the Merger Agreement and (ii) shares of FCAC
    Class A common stock to certain investors in connection with the Private
    Placement, plus any additional shares pursuant to subscription agreements we
    may enter into prior to Closing:




Votes For    Votes Against   Abstentions
32,014,508      921,746        16,552



5. The Incentive Plan Proposal - To approve, assuming the Business Combination


    Proposal, the Charter Proposal and the Stock Issuance Proposal are approved
    and adopted, the Sharecare, Inc. 2021 Omnibus Incentive Plan (the "Incentive
    Plan"), including the authorization of the initial share reserve under the
    Incentive Plan:




Votes For    Votes Against   Abstentions
31,935,113      960,023        57,670


Item 7.01 Other Events.


On June 29, 2021, the Company issued a press release announcing the results of the Special Meeting.

A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.




Exhibit Number   Description
99.1               Press Release, dated June 29, 2021




                                       2

© Edgar Online, source Glimpses